Sarepta Therapeutics Earnings Surprises image   This SRPT earnings surprises page last updated 3/11/2024
Sarepta Therapeutics Earnings Surprises Chart
PeriodExpectedActualSurprise
Q4 2023 0.01 0.82 +0.81 (+8100%)
Q3 2023 -1.32 0.37 +1.69 (-128%)
Q2 2023 -1.89 -0.85 +1.04 (-55%)
Q1 2023 -1.38 -0.97 +0.41 (-30%)
Q4 2022 -1.35 -0.53 +0.82 (-61%)
Q3 2022 -1.43 -0.80 +0.63 (-44%)
Q1 2022 -1.27 -0.56 +0.71 (-56%)
Q4 2021 -1.13 -0.77 +0.36 (-32%)
Q3 2021 -1.89 -0.19 +1.70 (-90%)
Q2 2021 -1.29 -1.52 -0.23 (+18%)
Q1 2021 -1.78 -1.54 +0.24 (-13%)
Q4 2020 -1.77 -1.84 -0.07 (+4%)
Q3 2020 -1.71 -1.42 +0.29 (-17%)
Q2 2020 -1.72 -1.51 +0.21 (-12%)
Q1 2020 -1.78 -1.04 +0.74 (-42%)
Q4 2019 -1.86 -1.57 +0.29 (-16%)
Q3 2019 -1.36 -1.14 +0.22 (-16%)
Q2 2019 -1.37 -0.83 +0.54 (-39%)
Q1 2019 -1.68 -0.75 +0.93 (-55%)
Q4 2018 -1.04 -0.85 +0.19 (-18%)
Q3 2018 -0.82 -0.56 +0.26 (-32%)
Q2 2018 -0.84 -0.43 +0.41 (-49%)
Q1 2018 -0.32 -0.28 +0.04 (-12%)
Q4 2017 -0.32 -0.28 +0.04 (-12%)
Q3 2017 -0.86 -0.20 +0.66 (-77%)
Q2 2017 -0.88 -0.46 +0.42 (-48%)
Q1 2017 -0.32 -0.60 -0.28 (+88%)
Q4 2016 -1.33 -0.71 +0.62 (-47%)
Q4 2014 -0.84 -0.94 -0.10 (+12%)
Q3 2014 -0.96 -0.70 +0.26 (-27%)
Q2 2014 -0.76 -0.61 +0.15 (-20%)
Q1 2014 -0.80 -0.55 +0.25 (-31%)
Q4 2013 -0.69 -0.77 -0.08 (+12%)
Q3 2013 -0.65 -0.63 +0.02 (-3%)
Q2 2013 -0.67 -0.46 +0.21 (-31%)
Q1 2013 -0.62 -0.41 +0.21 (-34%)
Q4 2012 -0.29 -2.36 -2.07 (+714%)
Q2 2012 -0.19 0.36 +0.55 (-289%)
Sarepta Therapeutics Revenue Surprises Chart
PeriodExpectedActualSurprise
Q4 2023 385.81M 396.78M +10.97M (+3%)
Q3 2023 288.50M 331.82M +43.32M (+15%)
Q2 2023 264.45M 261.24M -3.21M (-1%)
Q1 2023 241.96M 253.50M +11.54M (+5%)
Q4 2022 248.34M 258.43M +10.09M (+4%)
Q3 2022 234.52M 230.27M -4.25M (-2%)
Q1 2022 206.44M 210.83M +4.39M (+2%)
Q4 2021 198.61M 201.46M +2.85M (+1%)
Q3 2021 173.42M 189.41M +15.99M (+9%)
Q2 2021 162.64M 164.09M +1.45M (+1%)
Q1 2021 143.33M 146.93M +3.60M (+3%)
Q4 2020 146.29M 145.14M -1.15M (-1%)
Q3 2020 137.43M 143.92M +6.49M (+5%)
Q2 2020 118.78M 137.36M +18.58M (+16%)
Q1 2020 119.15M 113.67M -5.48M (-5%)
Q4 2019 98.85M 100.11M +1.26M (+1%)
Q3 2019 96.99M 99.04M +2.05M (+2%)
Q2 2019 90.94M 94.67M +3.73M (+4%)
Q1 2019 86.55M 87.01M +461000 (+1%)
Q4 2018 86.02M 84.42M -1.60M (-2%)
Q3 2018 79.21M 78.49M -0.72M (-1%)
Q2 2018 67.77M 73.53M +5.76M (+8%)
Q1 2018 64.80M 64.60M -0.20M (-0%)
Q4 2017 55.35M 57.28M +1.93M (+3%)
Q3 2017 40.19M 45.95M +5.76M (+14%)
Q2 2017 22.85M 35.01M +12.16M (+53%)
Q1 2017 13.84M 16.34M +2.50M (+18%)
Q4 2016 5.03M 5.42M +391000 (+8%)
Q4 2014 1.52M 27000 -1.49M (+1776216%)
Q3 2014 2.75M 1.10M -1.65M (-60%)
Q2 2014 4.30M 2.60M -1.70M (-40%)
Q1 2014 3.54M 6.09M +2.55M (+72%)
Q4 2013 4.53M 2.60M -1.93M (-43%)
Q3 2013 4.57M 4.17M -0.40M (-9%)
Q2 2013 5.08M 3.00M -2.08M (-41%)
Q1 2013 5.85M 4.50M -1.35M (-23%)
Q4 2012 6.71M 7.30M +590000 (+9%)
Q2 2012 12.43M 11.20M -1.23M (-10%)
Quotes delayed 20 minutes

Email EnvelopeFree SRPT Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options

Next Earnings Date Calendar:

Fortrea Holdings (FTRE): 3/11/2024 7:00 AM
Overseas Shipholding Gr (OSG): 3/11/2024 7:30 AM
Genie Energy (GNE): 3/11/2024 7:30 AM
Curis (CRIS): 3/11/2024 8:00 AM
Ocular Therapeutix (OCUL): 3/11/2024 After close
Ranpak Hldgs (PACK): 3/11/2024 After close
NET Power (NPWR): 3/11/2024 After close
Heritage Insurance Hldgs (HRTG): 3/11/2024 After close
Assertio Holdings (ASRT): 3/11/2024 After close
Amylyx Pharma (AMLX): 3/11/2024 After close

More from the Next Earnings Dates Calendar

Earnings History:

Cue Biopharma (CUE): 3/9/2024 After close
Ovid Therapeutics (OVID): 3/8/2024 8:00 AM
America's Car-Mart (CRMT): 3/8/2024 8:00 AM
Sigmatron International (SGMA): 3/8/2024 8:00 AM
XOMA (XOMA): 3/8/2024 7:30 AM
Dixie Gr (DXYN): 3/8/2024 7:00 AM
Genesco (GCO): 3/8/2024 6:50 AM
Nine Energy Service (NINE): 3/7/2024 5:00 PM
Ring Energy (REI): 3/7/2024 After close
Team (TISI): 3/7/2024 After close

More from the Earnings History archive
Sarepta Therapeutics (SRPT) is categorized under the Healthcare sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

SRRA Historical Earnings
SRRK Historical Earnings
SRTS Historical Earnings
SSKN Historical Earnings
STAA Historical Earnings
STAB Historical Earnings
STE Historical Earnings
STIM Historical Earnings
STOK Historical Earnings
STRO Historical Earnings
On this page we presented the SRPT earnings surprises information for Sarepta Therapeutics, comparing the expected earnings versus the actual earnings quarter by quarter, with the resulting positive or negative percentage surprise. Any self directed investor doing their due diligence on SRPT (or any other given stock) can benefit from researching all of the Sarepta Therapeutics past earnings going backwards in time, including how often the company beat or missed the market's expectations. To help you with this Sarepta Therapeutics earnings surprise research, on this page we presented each quarter's resulting numbers for easy comparison. Studying these numbers can help an investor by providing important context with which to think about SRPT's next earnings report. In your continued research on Sarepta Therapeutics we hope you will be sure to check out the further links included for revenue and earnings history as well as next earnings dates for SRPT. Thanks for visiting, and the next time you need to research SRPT earnings surprises or those of another stock, we hope you'll think of our site as your go-to earnings surprises research resource of choice.

Recommended: REMX shares outstanding history, QUBT Options Chain, UTEK Videos.

 

Sarepta Therapeutics Earnings Surprises | www.NextEarningsDate.com | Copyright © 2020 - 2024, All Rights Reserved

Nothing in NextEarningsDate.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 9.5%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 9.5%.